 MIAMI, Jan. 06, 2022 GLOBE NEWSWIRE -- Fortress Biotech, Inc. NASDAQ: FBIO Fortress, an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the H.C. Wainwright BioConnect Virtual Conference scheduled to take place from Monday, January 10 through Thursday, January 13, 2022. The companys presentation will be available for on-demand viewing on Fortress website beginning Monday, January 10, 2022, at 7:00 a.m. EST and will remain available on the Events page under the News Media section of Fortress website: for approximately 30 days following the presentation. 